Lysophosphatidic acid is the unique platelet-activating substance in human malignant ascites.

Sandmann, G; Siess, W; Essler, Markus

Sandmann, G; Siess, W; Essler, Markus.

Affiliation

Sandmann G; Nuklearmedizinische Klinik und Poliklinik, Klinikum rechts der Isar, Ismaningerstr. 22, D-81675 Munich, Germany. Markus.Essler@gmx.de

Eur J Med Res ; 8(9): 397-404, 2003 Sep 29.

Article in En | MEDLINE | ID: mdl-14555295

Subject(s)

Ascites/metabolism; Ascites/pathology; Blood Platelets/drug effects; Lysophospholipids/pharmacology; Platelet Activation/drug effects; Blood Platelets/physiology; Calcium/metabolism; Calcium Signaling/drug effects; Hematologic Neoplasms/chemistry; Hematologic Neoplasms/metabolism; Hematologic Neoplasms/pathology; Humans; Platelet Aggregation/drug effects; Receptors, G-Protein-Coupled/agonists; Receptors, G-Protein-Coupled/metabolism; Receptors, Lysophosphatidic Acid

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ascites / Blood Platelets / Lysophospholipids / Platelet Activation Limits: Humans Language: En Journal: Eur J Med Res Journal subject: MEDICINA Year: 2003 Document type: Article Affiliation country: Germany Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links